Pharmaceutical Companies

Subscribe to industry newsletters

Share us

Advertise with us
Advertise & RatesMy Account
Company press officeList company
Recruitment packagesSubmit job ad
Download ratecard
Pfizer, NWU sign MOU for potential collaboration on pre-clinical R&D

Pfizer and North-West University have signed a MOU outlining the basis for potential scientific and technical collaborations.

3 Jul 2014 12:13

New exco for National Association of Pharmaceutical Manufacturers

The National Association of Pharmaceutical Manufacturers has announced its new exco. Taking over the reigns as the association's chairperson is Desmond Brothers, CEO of Ranbaxy, who will be assisted by the new vice-chairperson, Herman Grobler, COO of Cipla.

1 Jul 2014 11:23

Ascendis Health, MIC in R200-million empowerment deal

Ascendis Health announced last week that it has concluded an agreement with the Mineworkers Investment Company (MIC), which will see the BEE ownership in Ascendis increase over a three-year period.

1 Jul 2014 11:18

JSE investigates Aspen trading activity last week

The JSE said it is investigating trading activity in pharmaceutical stock Aspen, which took place ahead of last week's investor conference call and led to a major dip in the share price.

By Evan Pickworth 1 Jul 2014 10:15

Aspen says management comments taken "out of context"

Aspen Pharmacare is attempting to eliminate uncertainty regarding its second-half earnings by saying certain comments made by its management team at a conference call last week were misconstrued and taken out of context.

1 Jul 2014 06:36

MMI buys CareCross group

Insurer MMI Holdings has bought the CareCross Health Group for an undisclosed sum‚ which it says will allow it to reduce healthcare costs.

20 Jun 2014 10:28

Ascendis Health acquires Respiratory Care Africa for R145 million

Subject to the regulatory consent of the South African Competition Authorities, Ascendis Health has acquired Respiratory Care Africa, a specialist medical devices company, for R 145 million in a cash and shares deal.

17 Jun 2014 14:53

Glaxo in USD350m cancer deal with biotech specialist

LONDON, UK: British pharmaceuticals giant GlaxoSmithKline has agreed to a US$350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday, 2 June 2014.

3 Jun 2014 15:37

Adcock shareholders have PIC to thank for loss after CFR buyout

Had the Public Investment Corporation (PIC) not blown the Chilean pharmaceutical company CFR's bid for Adcock Ingram out of the water late last year, Adcock's shareholders would now have a huge return.

By Stuart Theobald 3 Jun 2014 11:03

Adcock Ingram announces decentralisation‚ drop in profit

Pharmaceutical and healthcare products group Adcock Ingram Holdings would be reorganised into a decentralised structure from 1 July‚ Kevin Wakeford‚ the recently appointed Chief Executive of the group said.

By Charlotte Mathews 29 May 2014 12:39

AstraZeneca Pharmaceuticals expands to Zambia

AstraZeneca Pharmaceuticals, operational in 11 sub-Saharan African countries, has announced that it is launching into Zambia, initially focusing on providing cardiovascular, respiratory and gastrointestinal drugs and expanding its product portfolio to cover diseases like oncology and diabetes.

28 May 2014 10:36

Imperial Health Sciences builds US $20-million warehouse in Kenya

Imperial Health Sciences announced late last week, the development of a new, state-of-the-art pharmaceutical storage and distribution facility in Nairobi, Kenya. The US$20-million investment is in response to the pressing need for improvements in the delivery of healthcare products in East Africa.

27 May 2014 10:03

Adcock Ingram appoints new CEO

The Board of Adcock Ingram has announced the appointment of Kevin Wakeford as chief executive officer, with immediate effect. Wakeford joins Adcock Ingram following more than 10 years' experience with the Bidvest Group Limited, where he led various companies within the group.

3 Apr 2014 16:45

Adcock Ingram's Louw quits

Jonathan Louw became the most high-profile casualty of the year-long battle that resulted in the Bidvest Group holding the single largest shareholding in drug maker Adcock Ingram. Louw quit as chief executive on Tuesday, 2 April 2014.

By Sikonathi Mantshantsha 3 Apr 2014 08:51

Show more
No jobs found